Visit 16 (12 months after transplantation, outpatient control, final study visit closure, (± 30 days)
ADVERSE EVENTS, COMPLICATIONS
This is the last study visit. Patients will have physical examinations and lab tests (AST, ALT, GGT, alkaline phosphatase, bilirubin, factor V, INR, platelets, creatinine, GFR). During this appointment, further examinations, modification of concomitant medications, adverse events, or post-transplant complications will be noted and treated according to the routine management of patients after liver transplantation if necessary. Results of these checks will be documented in the eCRF. This is also the final control, including study closure and liver contrast enhanced MRI/MRCP.Serious and adverse events will be evaluated throughout study participation.